References
Arora, P., Kempf, A., Nehlmeier, I., Schulz, S.R., Jäck, H.M., Pöhlmann, S., and Hoffmann, M. (2023). Omicron sublineage BQ.1.1 resistance to monoclonal antibodies. Lancet Infect Dis 23, 22–23.
Barlow, K.A., Ó Conchúir, S., Thompson, S., Suresh, P., Lucas, J.E., Heinonen, M., and Kortemme, T. (2018). Flex ddG: rosetta ensemble-based estimation of changes in protein-protein binding affinity upon mutation. J Phys Chem B 122, 5389–5399.
Cao, Y., Jian, F., Wang, J., Yu, Y., Song, W., Yisimayi, A., Wang, J., An, R., Chen, X., Zhang, N., et al. (2023). Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 614, 521–529.
Gruell, H., Vanshylla, K., Weber, T., Barnes, C.O., Kreer, C., and Klein, F. (2022). Antibody-mediated neutralization of SARS-CoV-2. Immunity 55, 925–944.
Hoffmann, M., Krüger, N., Schulz, S., Cossmann, A., Rocha, C., Kempf, A., Nehlmeier, I., Graichen, L., Moldenhauer, A.S., Winkler, M.S., et al. (2022). The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell 185, 447–456.e11.
Iketani, S., Liu, L., Guo, Y., Liu, L., Chan, J.F.W., Huang, Y., Wang, M., Luo, Y., Yu, J., Chu, H., et al. (2022). Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature 604, 553–556.
Kimura, I., Yamasoba, D., Tamura, T., Nao, N., Suzuki, T., Oda, Y., Mitoma, S., Ito, J., Nasser, H., Zahradnik, J., et al. (2022). Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell 185, 3992–4007.e16.
Park, Y.J., Pinto, D., Walls, A.C., Liu, Z., De Marco, A., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K.R., et al. (2022). Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science 378, 619–627.
Planas, D., Saunders, N., Maes, P., Guivel-Benhassine, F., Planchais, C., Buchrieser, J., Bolland, W.H., Porrot, F., Staropoli, I., Lemoine, F., et al. (2022). Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671–675.
Que, H., Chen, L., and Wei, X. (2023). SARS-CoV-2 variants, immune escape, COVID-19 vaccine, and therapeutic strategies. Sci China Life Sci 66, 406–410.
Sun, C., Kang, Y.F., Liu, Y.T., Kong, X.W., Xu, H.Q., Xiong, D., Xie, C., Liu, Y.H., Peng, S., Feng, G.K., et al. (2022a). Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants. Sig Transduct Target Ther 7, 42.
Sun, C., Xie, C., Bu, G.L., Zhong, L.Y., and Zeng, M.S. (2022b). Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. Sig Transduct Target Ther 7, 202.
Tzou, P.L., Tao, K., Pond, S.L.K., and Shafer, R.W. (2022). Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons. PLoS ONE 17, e0261045.
Wang, Q., Iketani, S., Li, Z., Liu, L., Guo, Y., Huang, Y., Bowen, A.D., Liu, M., Wang, M., Yu, J., et al. (2023). Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell 186, 279–286.e8.
Xie, X., Cheng, X., Wang, G., Zhang, B., Liu, M., Chen, L., Cheng, H., Hao, S., Zhou, J., Zhu, P., et al. (2021). Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19. Sci China Life Sci 64, 1634–1644.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (82030046). We acknowledge the support from National Supercomputer Center, Guangzhou with the Tianhe-2 supercomputer. We would also like to thank EditChecks (https://editchecks.com.cn/) for providing linguistic assistance during the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Compliance and ethics The author(s) declare that they have no conflict of interest. All data are available in the manuscript or the supplementary materials. The flexddG pipeline used in this study is available at the Github repository (https://github.com/bigtaotao/Omicron_Sublineages_Analysis). All structural representations were generated using ChimeraX-1.1.1 or PyMOL. The protein complex structures used in this study are available at PDB (Accession numbers: 7mmo, 6wps, 6xdg, 7kmg, 7c01, 7cm4, 8d8q, 8gx9, 7u2d, 7ch4, 7k8z, 7k90, 7sbu, 7dk0, 7cwt, 7byr, 7b3o, 7ral, 7c2l, 7l2e, and 7rw2).
Rights and permissions
About this article
Cite this article
Sun, C., Liu, YT., Kang, YF. et al. Elucidation of the neutralizing antibody evasion of emergent SARS-CoV-2 Omicron sub-lineages using structural analysis. Sci. China Life Sci. 66, 2935–2938 (2023). https://doi.org/10.1007/s11427-023-2393-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-023-2393-3